Home > Resources > Company Profiles > Thermo Fisher Scientific, Incorporated

Thermo Fisher Scientific, Incorporated (TMO)

Your Name

Your Email Address *
Send a copy to me

Recipient's Email Address *

Separate multiple email addresses (max 20) with commas.

Subject *

Message

0/1500

Enter the text you see in the image *

Letters are not case-sensitive, disregard spaces.

Try a New One

This helps us prevent automated registrations and spamming.

Email Confirmation

Marijn E. Dekkers , CEO/President/Director

www.thermofisher.com

Industry: Technology

OPEN

LAST

PREV CLOSE

CHANGE

VOLUME

Overview

News

People

Financials

Overview

The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics to make the world healthier, cleaner and safer.

News Feeds

Thermo Fisher Scientific buys FiberLite Centrifuge AP
Jul 25 2008
Thermo Fisher posts 52 pct increase in net income AP
Jul 24 2008
Thermo Fisher buys Affinity BioReagents AP
Jul 17 2008
Thermo raising prices to offset higher costs AP
Jul 09 2008
Wall Street expects more M&A in life sciences AP
Jul 01 2008
Thermo Fisher Scientific acquires Open Biosystems AP
Jul 01 2008

Press Releases

Thermo Fisher Scientific Reports Record 2008 Second Quarter Results Jul-24-2008, 05:00AM EDT
Thermo Fisher Scientific Acquires Affinity BioReagents Jul-17-2008, 09:00AM EDT
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 24, 2008 Jul-08-2008, 04:10PM EDT
Thermo Fisher Scientific Acquires Open Biosystems, Creating Unmatched RNAi Platform Jul-01-2008, 08:23AM EDT
Thermo Fisher Scientific Elects New Director Jun-27-2008, 01:00PM EDT

News From Around the Web

News

Thermo Fisher Scientific Acquires FIBERLite Centrifuge, Inc. (MSN Money)

Jul 25 2008
Thermo Fisher Scientific buys FIBERLite - Update (RTTNews)

Jul 25 2008
Inverness and Thermo Fisher extend distribution agreement (Mass High Tech)

Jul 25 2008
Thermo Fisher produces record 2nd quarter revenue (Boston Business Journal)

Jul 25 2008
Market Report -- In Play (IMA) (MSN Money)

Jul 24 2008
Thermo Fisher posts 52 pct increase in net income (Businessweek)

Jul 24 2008
Thermo Fisher q2 profit surges - Update (RTTNews)

Jul 24 2008
Market Report -- In Play (TMO) (MSN Money)

Jul 24 2008
UPDATE 1-Thermo Fisher 2nd-quarter profit jumps 52 percent (Reuters)

Jul 24 2008
Thermo Fisher net climbs 52%, edges past estimate (MarketWatch)

Jul 24 2008

Employees

Number of Employees: 33,000

Revenue per Employee: $288,334

Top Executives

Fredric T. Walder, Senior VP, Divisional

Seth H. Hoogasian, Senior VP/Secretary/General Counsel

Marc N. Casper, Executive VP/COO

Peter E. Hornstra, Vice President/Chief Accounting Officer

Alan J. Malus, Senior VP

Guy Broadbent, Senior VP

Joseph R. Massaro, Senior VP, Divisional

Alexander G. Stachtiaris, Senior VP, Divisional

Peter M. Wilver, Senior VP/CFO

Stephen G. Sheehan, Senior VP, Divisional

Board of Directors

Seth H. Hoogasian, Senior VP/Secretary/General Counsel

Michael A. Bell, Director

Elaine S. Ullian, Director

Scott M. Sperling, Director

Judy C. Lewent, Director

Bruce L. Koepfgen, Director

William G. Parrett, Director

Peter J. Manning, Director

Jim P. Manzi, Chairman of the Board/Director

Stephen P. Kaufman, Director

Dr.Michael E. Porter, Director

Financials

Quarterly

Annual

Income Statement	04/2008	02/2008	10/2007	07/2007
Sales	1.66 Bil.	NA	1.27 Bil.	1.26 Bil.
Gross Operating Profit	898.9 Mil.	2.62 Bil.	1.14 Bil.	1.12 Bil.
Operating Income before D & A (EBITDA)	295.3 Mil.	2.62 Bil.	450.4 Mil.	438.4 Mil.
Total Income Before Interest Expenses (EBIT)	308 Mil.	2.62 Bil.	267.8 Mil.	255.5 Mil.
Total Net Income	233 Mil.	239.8 Mil.	218.5 Mil.	163.9 Mil.
Basic EPS, Total	0.56	0.57	0.51	0.39
Diluted EPS, Total	0.54	0.54	0.49	0.37

BALANCE STATEMENT	04/2008	02/2008	10/2007	07/2007
Cash and Equivalents	734 Mil.	636.2 Mil.	830.8 Mil.	951.2 Mil.
Total Assets	3.99 Bil.	3.68 Bil.	3.91 Bil.	4.01 Bil.
Total Liabilities	1.91 Bil.	1.91 Bil.	1.63 Bil.	1.6 Bil.
Total Capitalization	17.54 Bil.	16.53 Bil.	16.62 Bil.	16.71 Bil.

Cash Flow	04/2008	02/2008	10/2007	07/2007
Net Cash From Continuing Operations	NA	NA	926.6 Mil.	532.5 Mil.
Net Cash From Investing Activities	NA	NA	-135.8 Mil.	-33.6 Mil.
Net Cash From Financing Activities	NA	NA	-635.5 Mil.	-220.6 Mil.
Net Change in Cash & Cash Equivalents	NA	NA	163.4 Mil.	283.8 Mil.

Income Statement	2008	2007	2006	2005
Sales	6.39 Bil.	1.98 Bil.	1.31 Bil.	1.13 Bil.
Gross Operating Profit	3.36 Bil.	1.81 Bil.	1.32 Bil.	1.08 Bil.
Operating Income before D & A (EBITDA)	1.02 Bil.	528.44 Mil.	403.66 Mil.	319.48 Mil.
Total Income Before Interest Expenses (EBIT)	1.11 Bil.	261.3 Mil.	312.61 Mil.	259.22 Mil.
Total Net Income	761.1 Mil.	168.94 Mil.	223.22 Mil.	361.84 Mil.
Basic EPS, Total	1.81	0.86	1.38	2.22
Diluted EPS, Total	1.72	0.84	1.36	2.17

BALANCE STATEMENT	2008	2007	2006	2005
Cash and Equivalents	636.2 Mil.	667.43 Mil.	214.33 Mil.	326.89 Mil.
Total Assets	3.68 Bil.	3.66 Bil.	1.35 Bil.	1.47 Bil.
Total Liabilities	1.91 Bil.	2.15 Bil.	791.66 Mil.	578.73 Mil.
Total Capitalization	16.53 Bil.	16.09 Bil.	3.26 Bil.	2.89 Bil.

Cash Flow	2008	2007	2006	2005
Net Cash From Continuing Operations	NA	410.11 Mil.	272.79 Mil.	250.01 Mil.
Net Cash From Investing Activities	NA	283.45 Mil.	-753.48 Mil.	34.15 Mil.
Net Cash From Financing Activities	NA	-260.1 Mil.	390.86 Mil.	-183.22 Mil.
Net Change in Cash & Cash Equivalents	NA	453.11 Mil.	-112.56 Mil.	131.11 Mil.

Thermo Fisher Scientific, Incorporated (TMO)

Company Information

Overview

Employees

Top Executives

Board of Directors

Financials

Company Profile Change Request